Vankomicin PharmaS 125 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vankomicin pharmas 125 mg tvrde kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - vankomicinklorid - kapsula, tvrda - urbroj: svaka kapsula sadrži 125 mg vankomicinklorida što odgovara 125 000 iu vankomicina

Vankomicin PharmaS 250 mg tvrde kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

vankomicin pharmas 250 mg tvrde kapsule

pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - vankomicinklorid - kapsula, tvrda - urbroj: svaka kapsula sadrži 250 mg vankomicinklorida što odgovara 250 000 iu vankomicina

Nurodur 300 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

nurodur 300 mg tablete s produljenim oslobađanjem

reckitt benckiser d.o.o., ulica grada vukovara 269d, zagreb, hrvatska - ibuprofen - tableta s produljenim oslobađanjem - urbroj: jedna tableta sadrži 300 mg ibuprofena

Zexitor 1000 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zexitor 1000 mg tablete s produljenim oslobađanjem

novatin limited, 230, second floor, eucharistic congress road, mosta, malta - metforminklorid - tableta s produljenim oslobađanjem - urbroj: jedna tableta s produljenim oslobađanjem sadrži 1000 mg metforminklorida, što odgovara 780 mg metformina

Zexitor 500 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zexitor 500 mg tablete s produljenim oslobađanjem

novatin limited, 230, second floor, eucharistic congress road, mosta, malta - metforminklorid - tableta s produljenim oslobađanjem - urbroj: jedna tableta s produljenim oslobađanjem sadrži 500 mg metforminklorida, što odgovara 390 mg metformina

Zexitor 750 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

zexitor 750 mg tablete s produljenim oslobađanjem

novatin limited, 230, second floor, eucharistic congress road, mosta, malta - metforminklorid - tableta s produljenim oslobađanjem - urbroj: jedna tableta s produljenim oslobađanjem sadrži 750 mg metforminklorida, što odgovara 585 mg metformina

Kauliv Europska Unija - hrvatski - EMA (European Medicines Agency)

kauliv

strides pharma (cyprus) limited - teriparatid - osteoporosis; osteoporosis, postmenopausal - homeostaza kalcija - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Sorafenib Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

sorafenib accord

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastična sredstva - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Plerixafor Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

plerixafor accord

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - Иммуностимуляторы, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.